- Home
- UGP vs NAMS Comparison
UGP vs NAMS Comparison
Compare UGP & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGP
- NAMS
- Stock Information
- Founded
- UGP 1937
- NAMS 2019
- Country
- UGP Brazil
- NAMS Netherlands
- Employees
- UGP N/A
- NAMS N/A
- Industry
- UGP Oil/Gas Transmission
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- UGP Utilities
- NAMS Health Care
- Exchange
- UGP Nasdaq
- NAMS Nasdaq
- Market Cap
- UGP 3.2B
- NAMS 2.7B
- IPO Year
- UGP 1999
- NAMS N/A
- Fundamental
- Price
- UGP $3.37
- NAMS $25.00
- Analyst Decision
- UGP Buy
- NAMS Strong Buy
- Analyst Count
- UGP 2
- NAMS 9
- Target Price
- UGP $4.10
- NAMS $41.00
- AVG Volume (30 Days)
- UGP 1.7M
- NAMS 797.8K
- Earning Date
- UGP 08-13-2025
- NAMS 08-06-2025
- Dividend Yield
- UGP 3.25%
- NAMS N/A
- EPS Growth
- UGP 1.70
- NAMS N/A
- EPS
- UGP 0.48
- NAMS N/A
- Revenue
- UGP $25,352,989,456.00
- NAMS $64,006,000.00
- Revenue This Year
- UGP $3.76
- NAMS N/A
- Revenue Next Year
- UGP $1.59
- NAMS $73.09
- P/E Ratio
- UGP $6.64
- NAMS N/A
- Revenue Growth
- UGP 7.38
- NAMS 762.15
- 52 Week Low
- UGP $2.53
- NAMS $14.06
- 52 Week High
- UGP $4.38
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- UGP 61.81
- NAMS 59.65
- Support Level
- UGP $3.11
- NAMS $23.69
- Resistance Level
- UGP $3.33
- NAMS $25.90
- Average True Range (ATR)
- UGP 0.09
- NAMS 1.29
- MACD
- UGP 0.02
- NAMS -0.06
- Stochastic Oscillator
- UGP 94.60
- NAMS 80.69
About UGP Ultrapar Participacoes S.A.
Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The Company has three business segments: Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. The Ipiranga engages in the distribution and sale of oil-related products, biofuels, and similar products to service stations that operate under the Ipiranga brand throughout Brazil and to consumers and carrier-reseller-retailer. The Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers of Brazil.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.